Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells
Elizabeth A. LaMarca, Samuel K. Powell, Schahram Akbarian, et al.
Frontiers in Pediatrics (2018) Vol. 6
Open Access | Times Cited: 18

Showing 18 citing articles:

Tissue Response to Neural Implants: The Use of Model Systems Toward New Design Solutions of Implantable Microelectrodes
Maurizio Gulino, Dong‐Hoon Kim, Salvador Pané, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 124
An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack KNa Currents
Imran H. Quraishi, Shani Stern, Kile P. Mangan, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 37, pp. 7438-7449
Open Access | Times Cited: 97
Therapeutic importance of hydrogen sulfide in age-associated neurodegenerative diseases
NaYoung Jeong, Junyang Jung, Rubaiya Tabassum
Neural Regeneration Research (2019) Vol. 15, Iss. 4, pp. 653-653
Open Access | Times Cited: 52
Apitherapy for Parkinson’s Disease: A Focus on the Effects of Propolis and Royal Jelly
Amira Mohammed Ali, Hiroshi Kunugi
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 49
Development of two-photon polymerised scaffolds for optical interrogation and neurite guidance of human iPSC-derived cortical neuronal networks
J. A. Crowe, Ayman El-Tamer, David A. Nagel, et al.
Lab on a Chip (2020) Vol. 20, Iss. 10, pp. 1792-1806
Open Access | Times Cited: 25
CRISPR/Cas9 Genome Editing Approaches for Psychiatric Research
Araceli Gutiérrez-Rodríguez, Carlos Cruz-Fuentes, Alma Delia Genis‐Mendoza, et al.
Brazilian Journal of Psychiatry (2023)
Open Access | Times Cited: 8
Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk
Samuel K. Powell, Callan O’Shea, Kayla G. Townsley, et al.
Molecular Psychiatry (2021) Vol. 28, Iss. 5, pp. 1970-1982
Open Access | Times Cited: 20
Induced Pluripotency: A Powerful Tool for In Vitro Modeling
Romana Záhumenská, Vladimír Nosáľ, Marek Smolár, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8910-8910
Open Access | Times Cited: 20
The deep biology of cognition: Moving toward a comprehensive neurodevelopmental model of Turner syndrome
Rebecca Knickmeyer, Stephen R. Hooper
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2019) Vol. 181, Iss. 1, pp. 51-59
Closed Access | Times Cited: 19
Brain and Retinal Organoids for Disease Modeling: The Importance of In Vitro Blood–Brain and Retinal Barriers Studies
Ilenia Martinelli, Seyed Khosrow Tayebati, Daniele Tomassoni, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1120-1120
Open Access | Times Cited: 9
National Institute on Drug Abuse genomics consortium white paper: Coordinating efforts between human and animal addiction studies
Hannah M. Cates, Chelsie E. Benca‐Bachman, Giordano de Guglielmo, et al.
Genes Brain & Behavior (2019) Vol. 18, Iss. 6
Open Access | Times Cited: 12
Stem cells technology: a powerful tool behind new brain treatments
Lucienne Nneoma Duru, Zhenzhen Quan, Talal Jamil Qazi, et al.
Drug Delivery and Translational Research (2018) Vol. 8, Iss. 5, pp. 1564-1591
Closed Access | Times Cited: 5
Induction of Dopaminergic Neurons for Neuronal Subtype-Specific Modeling of Psychiatric Disease Risk
Samuel K. Powell, Callan O’Shea, Kayla G. Townsley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics
Eva Tomaskovic‐Crook, Kyle Guerrieri-Cortesi, Jeremy M. Crook
Brain Research Bulletin (2021) Vol. 175, pp. 48-62
Closed Access | Times Cited: 5
Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
Alain Ndayisaba, Marcos Herrera-Vaquero, Gregor K. Wenning, et al.
Clinical Autonomic Research (2019) Vol. 29, Iss. 4, pp. 385-395
Open Access | Times Cited: 2
Modeling rare pediatric neurogenetic disorders with IPSCs
Jaemin Kim, David Nonis, María Gabriela Otero, et al.
AIMS Cell and Tissue Engineering (2019) Vol. 3, Iss. 1, pp. 1-25
Open Access | Times Cited: 1
CRISPR/Cas9 mediated gene knockout of Glb1 gene in mouse embryonic fibroblasts
Ali Zarei, Vahid Razban, Kaoru Tabei, et al.
Gene Reports (2019) Vol. 16, pp. 100419-100419
Closed Access | Times Cited: 1
From Zero to Neuro-Reprogramming: Innovations in Translational Neuroregenerative Medicine
Ahmad Galuta, Eve C. Tsai
University of Ottawa Journal of Medicine (2019) Vol. 9, Iss. 1, pp. 54-60
Open Access
Page 1

Scroll to top